Use of complementary and alternative medicine among patients: Classification criteria determine level of use

Journal of Alternative and Complementary Medicine

Volumn 14, Issue 8, 2008, Pages 911-919

  Kristoffersen, Agnete Egilsdatter ^a   Fønnebø, Vinjar ^a   Norheim, Arne Johan ^a  

^a UNIVERSITY OF TROMSØ   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT;

ACUPUNCTURE; ALTERNATIVE MEDICINE; AROMATHERAPY; ARTICLE; BREAST CANCER; CHIROPRACTIC; CONTROLLED STUDY; DIET THERAPY; HOMEOPATHY; HUMAN; HYPNOSIS; KINESIOLOGY; KINESIOTHERAPY; MASSAGE; MEDITATION; MUSIC THERAPY; OZONE THERAPY; PATIENT CODING; PREVALENCE; PRIORITY JOURNAL; RELAXATION TRAINING; VITAMIN SUPPLEMENTATION; YOGA;

COMPLEMENTARY THERAPIES; DIETARY SUPPLEMENTS; EXERCISE; FAITH HEALING; FEMALE; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; LIFE STYLE; MALE; NEOPLASMS; NONPRESCRIPTION DRUGS; NORWAY; PATIENT ACCEPTANCE OF HEALTH CARE; PATIENT SATISFACTION; SELF CARE;

EID: 55749086622     PISSN: 10755535     EISSN: None     Source Type: Journal    
DOI: 10.1089/acm.2008.0127     Document Type: Article

References (36)

1. Eidinger RN, Schapira DV. Cancer patients' insight into their treatment, prognosis, and unconventional therapies. Cancer 1984;53:2736-2740.
2. Cui Y, Shu XO, Gao Y, et al. Use of complementary and alternative medicine by Chinese women with breast cancer. Breast Cancer Res Treat 2004;85:263-270.
3. Ernst E, Cassileth BR. The prevalence of complementary/alternative medicine in cancer: A systematic review. Cancer 1998;83:777-782.
4. Cassileth BR, Vickers AJ. High prevalence of complementary and alternative medicine use among cancer patients: Implications for research and clinical care. J Clin Oncol 2005;23:2590-2592.
5. Risberg T, Lund E, Wist E, et al. Cancer patients use of nonproven therapy: A 5-year follow-up study. J Clin Oncol 1998;16:6-12.
6. Yates JS, Mustian KM, Morrow GR, et al. Prevalence of complementary and alternative medicine use in cancer patients during treatment. Support Care Cancer 2005;13:806-811.
7. Richardson MA, Sanders T, Palmer JL, et al. Complementary/alternative medicine use in a comprehensive cancer center and the implications for oncology. J Clin Oncol 2000;18:2505-2514.
8. Eisenberg DM, Kessler RC, Foster C, et al. Unconventional medicine in the United States: Prevalence, costs, and patterns of use. NEJM 1993;328:246-252.
9. Sparber A, Bauer L, Curt G, et al. Use of complementary medicine by adult patients participating in cancer clinical trials. Oncol Nurs Forum 2000;27:623-630.
10. Hann D, Baker F, Denniston M, et al. Long-term breast cancer survivors' use of complementary therapies: Perceived impact on recovery and prevention of recurrence. Integr Cancer Ther 2005;4:14-20.
11. Sibbritt D, Adams J, Easthope G, et al. Complementary and alternative medicine (CAM) use among elderly Australian women who have cancer. Support Care Cancer 2003;11:548-550.
12. Shmueli A, Shuval J. Complementary and alternative medicine: Beyond users and nonusers. Complement Ther Med 2006;14:261-267.
13. WHO: General Guidelines for Methodologies on Research and Evaluation of Traditional Medicine. Online document at: www.ordinefoce.it/site/varieda0304/ WHO4.doc Accessed October 15, 2008.
14. NCCAM. What Is Complementary and Alternative Medicine (CAM)? NCCAM publication no. D347 February 2007. Online document at: http://nccam.nih.gov/ health/whatiscam/pdf/D347.pdf Accessed October 15, 2008.
15. House of Lords. Complementary and Alternative Medicine: Science and Technology, Sixth Report. Online document at: www.publications.parliament.uk/pa/ ld199900/ldselect/ldstech/123/12 Accessed October 15, 2008.
16. Balneaves LG, Bottorff JL, Hislop TG, Herbert C. Levels of commitment: Exploring complementary therapy use by women with breast cancer. J Altern Complement Med 2006;12:459-466.
17. Harris P, Rees R. The prevalence of complementary and alternative medicine use among the general population: A systematic review of the literature. Complement Ther Med 2000;8:88-96.
18. Harris P, Finlay IG, Cook A, et al. Complementary and alternative medicine use by patients with cancer in Wales: A cross sectional survey. Complement Ther Med 2003;11:249-253.
19. Tataryn DJ. Paradigms of health and disease: A framework for classifying and understanding complementary and alternative medicine. J Altern Complement Med 2002;8:877-892.
20. Barnes P, Powell-Griner E, McFann K, Nahin R. CDC Advance Data Report #343: Complementary and Alternative Medicine Use Among Adults. United States, 2002 May 27, 2004. Online document at: http://nccam.nih.gov/news/report.pdf Accessed October 15, 2008.
21. Molassiotis A, Scott JA, Kearney N, et al. Complementary and alternative medicine use in breast cancer patients in Europe. Support Care Cancer 2006;14:260-267.
22. Lee MM, Lin SS, Wrench MR, et al. Alternative therapies used by women with breast cancer in four ethnic populations. J Natl Cancer Inst 2000;92:42-47.
23. Boon H, Stewart M, Kennard MA, et al. Use of complementary/alternative medicine by breast cancer survivors in Ontario: Prevalence and perceptions. J Clin Oncol 2000;18:2515-2521.
24. Boon HS, Olatunde F, Zick SM. Trends in complementary/alternative medicine use by breast cancer survivors: Comparing survey data from 1998 and 2005. BMC Womens Health 2007;7:4.
25. Burstein HJ, Gelber S, Guadagnoli E, et al. Use of alternative medicine by women with early-stage breast cancer. NEJM 1999;340:1733-1739.
26. Ashikaga T, Bosompra K, O'Brien P, et al. Use of complementary and alternative medicine by breast cancer patients: Prevalence, patterns and communication with physicians. Support Care Cancer 2002;10:542-548.
27. Gray RE, Fitch M, Goel V, et al. Utilization of complementary/alternative services by women with breast cancer. J Health Soc Policy 2003;16:75-84.
28. Damkier A, Paludan-Muller C, Knoop AS. Use of complementary and alternative medicine (CAM) in breast cancer patients: Efficacy and interactions. Ugeskr Laeger 2007;169:3111-3114.
29. Buettner C, Kroenke CH, Phillips RS, et al. Correlates of use of different types of complementary and alternative medicine by breast cancer survivors in the nurses' health study. Breast Cancer Res Treat 2006;100:219-227.
30. Yap KP, McCready DR, Fyles A, et al. Use of alternative therapy in postmenopausal breast cancer patients treated with tamoxifen after surgery. Breast J 2004;10:481-486.
31. Nagel G, Hoyer H, Katenkamp D. Use of complementary and alternative medicine by patients with breast cancer: Observations from a health-care survey. Support Care Cancer 2004;12:789-796.
32. Ahn JH, Kim SB, Yun MR, et al. Alternative therapy and abnormal liver function during adjuvant chemotherapy in breast cancer patients. J Korean Med Sci 2004;19:397-400.
33. Rakovitch E, Pignol JP, Chartier C, et al. Complementary and alternative medicine use is associated with an increased perception of breast cancer risk and death. Breast Cancer Res Treat 2005;90:139-148.
34. Henderson JW, Donatelle RJ. Complementary and alternative medicine use by women after completion of allopathic treatment for breast cancer. Altern Ther Health Med 2004;10:52-57.
35. Matthews AK, Sellergren SA, Huo D, et al. Complementary and alternative medicine use among breast cancer survivors. J Altern Complement Med 2007;13:555-562.
36. Tromsø TUo: The Tromsø study. Online document at: http://uit.no/tromsoundersokelsen/forsiden/?Language=en Accessed October 15, 2008.